v3.24.3
Condensed Consolidated Statements of Operations and Comprehensive Loss (Unaudited) - USD ($)
$ in Thousands
3 Months Ended 9 Months Ended
Sep. 30, 2024
Sep. 30, 2023
Sep. 30, 2024
Sep. 30, 2023
Revenues [Abstract]        
Product sales $ 434 $ 3,248 $ 3,012 $ 4,897
Other revenue 159 383 630 647
Total revenues 593 3,631 3,642 5,544
Cost of revenues 358 1,454 1,587 2,347
Gross profit 235 2,177 2,055 3,197
Operating expenses:        
Selling, general and administrative 3,334 4,317 11,029 12,604
Research and development 527 610 1,960 2,683
Total operating expenses 3,861 4,927 12,989 15,287
Loss from operations (3,626) (2,750) (10,934) (12,090)
Nonoperating Income (Expense) [Abstract]        
Interest income 21 90 154 413
Change in fair value of warranty liabilities 5,600 (117) 12,517 (117)
Other (5) (6) (15) (25)
Total other income (expense), net 5,616 (33) 12,656 271
Net income (loss) 1,990 (2,783) 1,722 (11,819)
Less: convertible preferred stock dividends (317) (193) (1,017) (193)
Net income (loss) attributable to common stockholders $ 1,673 $ (2,976) $ 705 $ (12,012)
Net income (loss) per basic and diluted common share (in dollars per share) $ 0.04 $ (0.07) $ 0.02 $ (0.29)
Weighted average common shares used to compute net loss per basic and diluted common share (in shares) 45,861,208 42,652,481 45,067,793 41,914,512
Comprehensive income (loss):        
Net income (loss) $ 1,990 $ (2,783) $ 1,722 $ (11,819)
Comprehensive income (loss) $ 1,990 $ (2,783) $ 1,722 $ (11,819)

Source